CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (loss)	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2022		412,385
Beginning balance at Dec. 31, 2022	$ 1,040,609	$ 4,124	$ 2,106,886	$ (1,064,230)	$ (5,560)	$ (611)
Total Stockholders’ Equity (Deficit)
Net income (loss)	(262,803)			(262,596)		(207)
Other comprehensive income (loss)	3,262				3,262
Exercise of stock options (in shares)		2,786
Exercise of stock options	13,714	$ 28	13,686
Vesting of restricted stock units (in shares)		899
Vesting of restricted stock units	0	$ 9	(9)
Shares withheld related to net share settlement (in shares)		(68)
Shares withheld related to net share settlement	$ (1,847)	$ (1)	(1,846)
Common stock repurchase (in shares)	(9,600)	(9,615)
Common stock repurchase	$ (201,409)	$ (96)	(201,313)
Stock-based compensation expense	69,495		69,495
Ending balance (in shares) at Dec. 31, 2023		406,387
Ending balance at Dec. 31, 2023	661,021	$ 4,064	1,986,899	(1,326,826)	(2,298)	(818)
Total Stockholders’ Equity (Deficit)
Net income (loss)	(260,101)			(260,151)		50
Other comprehensive income (loss)	2,210				2,210
Exercise of stock options (in shares)		1,508
Exercise of stock options	2,758	$ 15	2,743
Vesting of restricted stock units (in shares)		2,652
Vesting of restricted stock units	0	$ 27	(27)
Shares withheld related to net share settlement (in shares)		(327)
Shares withheld related to net share settlement	(1,591)	$ (3)	(1,588)
Issuance of common stock (in shares)		1,974
Issuance of common stock	15,230	$ 19	15,211
Stock-based compensation expense	50,657		50,657
Dissolution of partially owned entity	$ 768					768
Ending balance (in shares) at Dec. 31, 2024	412,194	412,194
Ending balance at Dec. 31, 2024	$ 470,952	$ 4,122	2,053,895	(1,586,977)	(88)	0
Total Stockholders’ Equity (Deficit)
Net income (loss)	(391,347)			(391,347)
Other comprehensive income (loss)	1,004				1,004
Exercise of stock options (in shares)		24
Exercise of stock options	110		110
Vesting of restricted stock units (in shares)		3,200
Vesting of restricted stock units	0	$ 32	(32)
Shares withheld related to net share settlement (in shares)		(690)
Shares withheld related to net share settlement	(3,104)	$ (7)	(3,097)
Stock-based compensation expense	$ 49,119		49,119
Ending balance (in shares) at Dec. 31, 2025	414,728	414,728
Ending balance at Dec. 31, 2025	$ 126,734	$ 4,147	$ 2,099,995	$ (1,978,324)	$ 916	$ 0